Abstract: An integrated circuit includes one or more portions having error detection and error correction circuits and which is operated with operating parameters giving finite non-zero error rate as well as one or more portions formed and operated to provide a zero error rate.
Type:
Application
Filed:
October 25, 2010
Publication date:
May 5, 2011
Applicants:
Arm Limited, The Regents of the University of Michgan
Inventors:
Krisztian Flautner, Todd Michael Austin, David Theodore Blaauw, Trevor Nigel Mudge, David Bull
Abstract: The present invention relates to methods and compositions for stimulating an immune response. Specifically, the present invention provides methods of inducing an immune response to an orthopox virus (e.g., vaccinia virus) in a subject (e.g., a human subject) and compositions useful in such methods (e.g., a nanoemulsion comprising vaccinia virus). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination) and research applications.
Type:
Application
Filed:
August 14, 2008
Publication date:
March 12, 2009
Applicant:
THE REGENTS OF THE UNIVERSITY OF MICHGAN
Inventors:
James R. Baker, JR., Anna Bielinska, Andrzej Myc
Abstract: The breakpoints of the pericentric inversion of chromosome 16 have been cloned. Two genes, one at each breakpoint, have also been identified, as well as several forms of the inversion 16 fusion gene. Diagnostic applications for chromosome 16 abnormalities and, particularly acute myeloid leukemia are also within the scope of the present invention.
Type:
Grant
Filed:
September 25, 1995
Date of Patent:
November 17, 1998
Assignees:
The Regents of the University of Michgan, The Board of Regents University of Texas System
Inventors:
Pu Liu, Francis S. Collins, Michael J. Siciliano, David Claxton
Abstract: Water-soluble, high-viscosity grade cellulose ether compositions are useful for the reduction of serum lipid levels, particularly total serum cholesterol, serum triglycerides, and low-density lipoprotein (LDL) levels and/or attenuate the postprandial rise of blood glucose levels in animals. The pharmaceutical uses of compositions for reducing cholesterol levels additionally include the treatment of diabetes and/or hypercholesterolemia, with avoidance of many of the undesirable side effects associated with other forms of treatment. The composition may be in the form of a prehydrated ingestible composition, such as a gelatin, or a comestible, such as a cookie. In addition, the compositions of the present invention are palatable to the patient, thereby enhancing patient compliance with the regimen.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
August 4, 1998
Assignees:
The Board of Regents of the University of Michgan, The Dow Chemical Company
Inventors:
Jennifer B. Dressman, Christos Reppas, Stephen W. Tobey, Cynthia W. Sowle